The COUP-TFII is a multifunctional transcription inhibitor, which has been confirmed to inhibit the expression of aromatase, cyclooxygenase-2 (COX-2), and angiopoietin in the endometriosis stromal cells. The gene discussed is CYP19A1; the disease is endometriosis.